Senior Principal Scientist
Genentech, Inc.
South San Francisco, California
Vittal Shivva is a Sr. Principal Scientist at the Preclinical and Translational Pharmacokinetics & Pharmacodynamics Department at Genentech, USA since 2017. Prior to joining Genentech, Vittal worked as a post-doctoral researcher at the Office of Generic Drugs, US FDA. Vittal received his Ph.D. in Pharmacology and Pharmacometrics from University of Otago, Dunedin, New Zealand in 2015, and completed doctoral internship at Novartis, Basel, Switzerland. Vittal has 15+ years of experience in Drug Discovery and Development. Prior to obtaining PhD, Vittal worked at various positions within the Department of Drug Metabolism and Pharmacokinetics at Drug Discovery Unit of Dr. Reddy’s Laboratories, Hyderabad, India and was involved in translational PKPD and early clinical development of small molecule therapeutics for cardiovascular, metabolic disorders and infectious diseases. Vittal’s current work at Genentech is focused heavily on understanding preclinical and translational PKPD aspects of protein therapeutics, specifically new treatment modalities such as T-cell dependent bispecific antibodies, engineered cytokines, cellular therapies and novel antibody conjugates in the area of cancer immunotherapy and ophthalmology.
AAPS Gene & Cell Therapy Products Community Membership Meeting
Monday, October 23, 2023
4:00 PM – 5:00 PM ET